The following is a reconciliation between basic and diluted weighted average shares outstanding:


	13 Weeks Ended				26 Weeks Ended
(In thousands)	August 1, 2026		August 2, 2025		August 1, 2026		August 2, 2025
Weighted average common shares outstanding:
Basic number of common shares outstanding:		167,059		170,756		167,447		175,156
Dilutive effect of stock options and non-vested restricted stock		3,121		903		3,830		1,326
Diluted number of common shares outstanding		170,180		171,659		171,277		176,482
Anti-Dilutive Shares (1)		1,917		4,151		1,913		3,518

(1) For all periods presented, anti-dilutive shares relate to outstanding stock options and unvested restricted stock units that have been excluded from the computation of earnings per diluted share because their effect is anti-dilutive.

Refer to Note 9, Share-Based Payments, to the Consolidated Financial Statements for additional information regarding share-based compensation.

On March 14, 2025, the Company entered into an accelerated share repurchase agreement (the "ASR Agreement") with Bank of America, N.A. ("Bank of America"), pursuant to which the Company made an aggregate payment of $200 million to Bank of America and received an aggregate initial delivery of approximately 14.5 million shares of its common stock on March 17, 2025. At final settlement on June 16, 2025, the Company received an additional 3.9 million shares. The cumulative repurchases under the ASR Agreement totaled 18.4 million shares, in the aggregate, at an average price of $10.86 per share. The aforementioned repurchased shares were recorded as treasury stock.